Occult Cancer study: FDG PET/CT
Official title Intensive Cancer Screening After Cryptogenic Stroke
ClinicalTrials.gov ID: NCT05733416
What this study is testing
- What it's testing
- This study checks if adding a special body scan to standard care helps doctors find hidden cancers more often in people who had a stroke with no clear reason.
- Who it's for
- The study is looking for adults who have had a stroke where the cause could not be found.
- What's involved
- Participants will receive either standard cancer screening or standard screening plus a full-body PET/CT scan (a test that uses a small amount of radioactive sugar to look for active cells).
- Time commitment
- The source text does not specify the total duration or number of visits required.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- adults ≥18 years
- presenting to the Ottawa Hospital Stroke Prevention Clinic or the Ottawa Hospital Neurovascular Unit with a first cryptogenic ischemic stroke after...
- patient or delegate willing and able to provide informed consent.
You likely can't join if
- contraindications to FDG PET/CT (pregnancy or unable to lie still in bed for 20 minutes)
- active cancer or previous cancer diagnosis (other than basal or squamous cell carcinoma of the skin)
The study team makes the final eligibility decision.
Where it is enrolling
- Ottawa, Ontario, Canada
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Ottawa, Ontario, Canada; Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.